Clinical Trial Update: Glucagon-Like Peptide-1 Receptor Agonist in ADPKD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an investigational GLP-1 receptor agonist for autosomal dominant polycystic kidney disease, with obesity as a co-listed cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease
• Obesity

Drugs mentioned

• GLP-1 Receptor Agonist (investigational) (GLP-1 receptor agonist)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Autosomal Dominant Polycystic Kidney, Obesity | Phase 2 | Status: RECRUITING